Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Daidzein Tablets

Approval Number

国药准字H44024969

Company广州白云山明兴制药有限公司

Registration Date

March 15, 2024

Drug Information

Generic Name

黄豆苷元片

Dosage Form

片剂

Strength

50mg

Drug Type

化学药品

Registration Date

March 15, 2024

Company Information

Applicant Company

Company Name广州白云山明兴制药有限公司

Company Address

广州市海珠区工业大道北48号

Manufacturing Company

Company Name广州白云山明兴制药有限公司

Company Address

广州市海珠区工业大道北48号

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy